Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097448 · ClinicalTrials.gov registry record · Phase 3
Sudden Deafness Treatment Trial
A Phase 3 study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- Phase 3
- Development phase
- 255
- Enrollment target
NCT00097448 is a Phase 3 study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 255 participants.
The verdict
NCT00097448, a Phase 3 study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 255 participants
- Enrollment target
Study Summary
This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).
Interventions
- DRUG prednisone
- DRUG methylprednisolone sodium succinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2004-12 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00097448
The ClinicalTrials.gov registry entry for NCT00097448 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which prednisone is the first listed.
NCT00097448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00097448 about?
NCT00097448 is a clinical study titled "Sudden Deafness Treatment Trial". This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).
What is the current status of trial NCT00097448?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 255 participants. The study started on 2004-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00097448?
The interventions under investigation include: prednisone (DRUG), methylprednisolone sodium succinate (DRUG).
Who is sponsoring clinical trial NCT00097448?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.